
    <!DOCTYPE html>
    <html lang="en" >
    <head>
      
      <meta charset="UTF-8">
      <meta name="viewport" content="width=device-width, initial-scale=1">
      <link rel="alternate" type="application/atom+xml" href="/feed" />

      <title data-react-helmet="true">Foundation Medicine - Foundation Medicine</title>

      <link rel="stylesheet" type="text/css" href="https://cloud.typography.com/6062776/7773772/css/fonts.css" />
      <link rel="stylesheet" href="/index.css?v=1.4.4">

      <!-- Favicons & App Icons -->
      <link rel="apple-touch-icon" sizes="57x57" href="/img/touch-icons/apple-touch-icon-57x57.png">
      <link rel="apple-touch-icon" sizes="60x60" href="/img/touch-icons/apple-touch-icon-60x60.png">
      <link rel="apple-touch-icon" sizes="72x72" href="/img/touch-icons/apple-touch-icon-72x72.png">
      <link rel="apple-touch-icon" sizes="76x76" href="/img/touch-icons/apple-touch-icon-76x76.png">
      <link rel="apple-touch-icon" sizes="114x114" href="/img/touch-icons/apple-touch-icon-114x114.png">
      <link rel="apple-touch-icon" sizes="120x120" href="/img/touch-icons/apple-touch-icon-120x120.png">
      <link rel="apple-touch-icon" sizes="144x144" href="/img/touch-icons/apple-touch-icon-144x144.png">
      <link rel="apple-touch-icon" sizes="152x152" href="/img/touch-icons/apple-touch-icon-152x152.png">
      <link rel="apple-touch-icon" sizes="180x180" href="/img/touch-icons/apple-touch-icon-180x180.png">
      <link rel="icon" type="image/png" href="/img/touch-icons/favicon-32x32.png" sizes="32x32">
      <link rel="icon" type="image/png" href="/img/touch-icons/favicon-96x96.png" sizes="96x96">
      <link rel="icon" type="image/png" href="/img/touch-icons/favicon-16x16.png" sizes="16x16">
      <link rel="shortcut icon" href="/img/touch-icons/favicon.ico">

      <meta data-react-helmet="true" name="description" content="Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease."/><meta data-react-helmet="true" property="og:title" content="Foundation Medicine"/><meta data-react-helmet="true" property="og:description" content="Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease."/><meta data-react-helmet="true" property="og:image" content="/img/og-logo.jpg"/><meta data-react-helmet="true" property="twitter:image" content="/img/og-logo.jpg"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" property="og:site_name" content="Foundation Medicine"/><meta data-react-helmet="true" property="og:locale" content="en_US"/><meta data-react-helmet="true" property="twitter:site" content="@FoundationATCG"/><meta data-react-helmet="true" property="twitter:card" content="summary"/><meta data-react-helmet="true" property="og:url" content="https://www.foundationmedicine.com/"/>
      <link data-react-helmet="true" rel="canonical" href="https://www.foundationmedicine.com/"/>

      <script src="//js.hs-scripts.com/174278.js" type="text/javascript" id="hs-script-loader" async defer></script>
    </head>
    <body>
      <div id="fmi-react"><div class="ScrollMagicController" data-reactroot="" data-reactid="1" data-react-checksum="1533077661"><div class="page-announcer js-page-announcer" aria-live="polite" data-reactid="2"></div><!-- react-empty: 3 --><div data-reactid="4"><div class="grid" data-reactid="5"><div class="grid__content base-layout" data-reactid="6"><div class="grid__col" data-reactid="7"></div><div class="grid__col" data-reactid="8"></div><div class="grid__col" data-reactid="9"></div><div class="grid__col" data-reactid="10"></div><div class="grid__col" data-reactid="11"></div><div class="grid__col" data-reactid="12"></div><div class="grid__col" data-reactid="13"></div><div class="grid__col" data-reactid="14"></div><div class="grid__col" data-reactid="15"></div><div class="grid__col" data-reactid="16"></div><div class="grid__col" data-reactid="17"></div><div class="grid__col" data-reactid="18"></div></div></div></div><div class="primary-header-wrapper" data-reactid="19"><a href="#main-content" id="skip-to-content" class="skip-to-content js-skip-to-content" data-reactid="20">skip to content</a><header class="primary-header" data-reactid="21"><div class="primary-header__content base-layout" data-reactid="22"><div class="primary-header__logo" data-reactid="23"><h1 class="primary-header__logo-h1" data-reactid="24"><a class="primary-header__logo-h1-link" href="/" data-reactid="25">Foundation Medicine</a></h1></div><div class="navigation" data-reactid="26"><div class="mobile-nav" data-reactid="27"><div class="mobile-navbar" data-reactid="28"><div class="login-logout" data-reactid="29"><div class="login" data-reactid="30"><button id="login-open-modal-button" class="navbar__link navbar__link--button" data-reactid="31">Log In</button><!-- react-empty: 32 --></div></div><button class="mobile-nav__menu-button" data-reactid="33">Menu</button></div><!-- react-empty: 34 --></div></div></div></header></div><main id="main-content" tabindex="-1" class="main" data-reactid="35"><div data-reactid="36"><!-- react-empty: 37 --><div class="home" data-reactid="38"><div class="Banner " data-reactid="39"><div class="legend-wrapper" data-reactid="40"><h2 class="legend" data-reactid="41"><!-- react-text: 42 -->FoundationOne CDx™ has now received FDA approval.<!-- /react-text --><!-- react-text: 43 --> <!-- /react-text --><a href="/genomic-testing/foundation-one-cdx" data-reactid="44">Learn more.</a></h2></div><button class="close-btn" data-reactid="45">close button</button></div><div class="home-hero home-hero__slides" data-reactid="46"></div><section class="home-preface" data-reactid="47"><div class="home-preface__content" data-reactid="48"><span class="contentful-text" data-reactid="49"><p>Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.
</p></span></div></section><section class="home-story-block home-story-block--today" data-reactid="50"><div class="scrollmagic-component" data-reactid="51"><svg class="triangle-svg home-story-block__triangle home-story-block__triangle--today" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 600 600" data-reactid="52"><g class="flat-pattern" fill="none" fill-rule="evenodd" stroke="#F7D18F" stroke-width="2" data-reactid="53"><path d="M-21.4350373,319.176612 L237.918186,319.176612" stroke-dasharray="1000" transform="translate(108.241574, 319.676612) rotate(90.000000) translate(-108.241574, -319.676612) " data-reactid="54"></path><polyline transform="translate(385.370673, 191.246094) rotate(90.000000) translate(-385.370673, -191.246094) " points="319.468329 136.616995 258.124579 245.062308 382.921831 245.875193 512.616767 245.062308" data-reactid="55"></polyline><polyline transform="translate(330.890012, 253.570312) rotate(90.000000) translate(-330.890012, -253.570312) " points="203.319699 146.003906 331.600949 362.71875 458.460324 144.421875 329.3279 144.421875 395.37634 252.447629" data-reactid="56"></polyline><polyline transform="translate(167.600557, 318.945626) rotate(90.000000) translate(-167.600557, -318.945626) " points="39.6549312 376.831952 102.467431 485.804608 295.546182 152.086643" data-reactid="57"></polyline><path d="M281.623047,15.1152344 L156.09668,239.176758" stroke-linecap="square" transform="translate(218.859863, 127.145996) rotate(90.000000) translate(-218.859863, -127.145996) " data-reactid="58"></path><polyline transform="translate(220.864928, 354.820229) rotate(90.000000) translate(-220.864928, -354.820229) " points="58.0446987 467.943583 121.220481 353.771288 383.685157 353.750595 312.632589 241.696875" data-reactid="59"></polyline><path d="M154.790613,271.950961 L286.558562,495.816988" stroke-linecap="square" transform="translate(220.674587, 383.883975) rotate(90.000000) translate(-220.674587, -383.883975) " data-reactid="60"></path><polygon transform="translate(162.623224, 95.823388) rotate(90.000000) translate(-162.623224, -95.823388) " points="258.446612 150.03707 193.934894 39.9417383 66.799836 41.6737883 130.946613 151.705038" data-reactid="61"></polygon></g></svg></div><div class="home-story-block__content" data-reactid="62"><h3 class="home-story-block__h3 home-story-block__h3--today" data-reactid="63"><!-- react-text: 64 -->Better Care <!-- /react-text --><em data-reactid="65">Today</em></h3><div class="home-story-block__offer-set" data-reactid="66"><div class="home-story-block__offer home-story-block__offer--today" data-reactid="67"><h6 class="home-story-block__number" data-reactid="68">1</h6><h4 class="home-story-block__h4" data-reactid="69"><span class="contentful-text" data-reactid="70">Genomic Testing</span></h4><h5 class="home-story-block__h5" data-reactid="71"><span class="contentful-text" data-reactid="72">Comprehensive Genomic Profiling</span></h5><div class="home-story-block__text" data-reactid="73"><span class="contentful-text" data-reactid="74"><p>Our <a rel="noopener noreferrer" href="/genomic-testing">portfolio of genomic tests</a> is the leading platform for comprehensive genomic profiling.  We interrogate more than 300 genes across all four classes of genomic alterations to help understand the genomic makeup of a patient's tumor.<br />
</p></span></div></div><div class="home-story-block__offer home-story-block__offer--today" data-reactid="75"><h6 class="home-story-block__number" data-reactid="76">2</h6><h4 class="home-story-block__h4" data-reactid="77"><span class="contentful-text" data-reactid="78">Molecular Insights</span></h4><h5 class="home-story-block__h5" data-reactid="79"><span class="contentful-text" data-reactid="80">Valuable Insights, Actionable Options</span></h5><div class="home-story-block__text" data-reactid="81"><span class="contentful-text" data-reactid="82"><p>We match each patient’s unique profile to known targeted therapies, immunotherapies and clinical trials and offer decision support tools, <a rel="noopener noreferrer" href="/genomic-testing#support-services">financial assistance</a>, and technology solutions to help streamline patient care.
</p></span></div></div></div></div></section><section class="flex-module flex-module--fire flex-module--media-module" data-reactid="83"><div class="flex-module__box flex-module__box--left" data-reactid="84"><h4 class="flex-module__microhead" data-reactid="85">Patient Story</h4><h3 class="flex-module__head flex-module__head--pullquote" data-reactid="86">Dealing with cancer is not just dealing with the cancer. It’s treating the whole person.</h3><div class="flex-module__line" data-reactid="87">|</div><div class="flex-module__tease" data-reactid="88"><span class="contentful-text" data-reactid="89"><p>Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining FoundationOne<sup>®</sup>, a comprehensive genomic profiling test.
</p></span></div></div><div class="flex-module__box flex-module__box--right" data-reactid="90"><img alt="" src="//images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg" srcset="//images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg?w=300 300w, //images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg?w=450 450w, //images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg?w=650 650w, //images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg?w=765 765w" sizes="
    (min-width: 1655px) 828px,
    (min-width: 768px) 50vw,
    calc(100vw)
  " data-reactid="91"/><div class="flex-module__video-modal" data-reactid="92"><button id="home-open-video-modal-button" class="flex-module__play-btn" data-reactid="93">Play</button></div></div></section><section class="home-story-block home-story-block--tomorrow" data-reactid="94"><div class="scrollmagic-component" data-reactid="95"><svg class="triangle-svg home-story-block__triangle home-story-block__triangle--tomorrow" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 600 600" data-reactid="96"><g class="flat-pattern" fill="none" fill-rule="evenodd" stroke="#F7D18F" stroke-width="2" data-reactid="97"><path d="M-21.4350373,319.176612 L237.918186,319.176612" stroke-dasharray="1000" transform="translate(108.241574, 319.676612) rotate(90.000000) translate(-108.241574, -319.676612) " data-reactid="98"></path><polyline transform="translate(385.370673, 191.246094) rotate(90.000000) translate(-385.370673, -191.246094) " points="319.468329 136.616995 258.124579 245.062308 382.921831 245.875193 512.616767 245.062308" data-reactid="99"></polyline><polyline transform="translate(330.890012, 253.570312) rotate(90.000000) translate(-330.890012, -253.570312) " points="203.319699 146.003906 331.600949 362.71875 458.460324 144.421875 329.3279 144.421875 395.37634 252.447629" data-reactid="100"></polyline><polyline transform="translate(167.600557, 318.945626) rotate(90.000000) translate(-167.600557, -318.945626) " points="39.6549312 376.831952 102.467431 485.804608 295.546182 152.086643" data-reactid="101"></polyline><path d="M281.623047,15.1152344 L156.09668,239.176758" stroke-linecap="square" transform="translate(218.859863, 127.145996) rotate(90.000000) translate(-218.859863, -127.145996) " data-reactid="102"></path><polyline transform="translate(220.864928, 354.820229) rotate(90.000000) translate(-220.864928, -354.820229) " points="58.0446987 467.943583 121.220481 353.771288 383.685157 353.750595 312.632589 241.696875" data-reactid="103"></polyline><path d="M154.790613,271.950961 L286.558562,495.816988" stroke-linecap="square" transform="translate(220.674587, 383.883975) rotate(90.000000) translate(-220.674587, -383.883975) " data-reactid="104"></path><polygon transform="translate(162.623224, 95.823388) rotate(90.000000) translate(-162.623224, -95.823388) " points="258.446612 150.03707 193.934894 39.9417383 66.799836 41.6737883 130.946613 151.705038" data-reactid="105"></polygon></g></svg></div><div class="home-story-block__content" data-reactid="106"><h3 class="home-story-block__h3 home-story-block__h3--tomorrow" data-reactid="107"><!-- react-text: 108 -->Better Care <!-- /react-text --><em data-reactid="109">Tomorrow</em></h3><div class="home-story-block__offer-set" data-reactid="110"><div class="home-story-block__offer home-story-block__offer--tomorrow" data-reactid="111"><h6 class="home-story-block__number" data-reactid="112">3</h6><h4 class="home-story-block__h4" data-reactid="113"><span class="contentful-text" data-reactid="114">More Than Numbers</span></h4><h5 class="home-story-block__h5" data-reactid="115"><span class="contentful-text" data-reactid="116">Insights, Not Just Information</span></h5><div class="home-story-block__text" data-reactid="117"><span class="contentful-text" data-reactid="118"><p>
	Our unique knowledgebase, <a href="http://www.foundationmedicine.com/insights-and-partnerships/foundation-insights" rel="noopener noreferrer">FoundationCore™</a>, is one of the world's largest cancer genomic databases, with more than 180,000 anonymized patient records, designed to help researchers and biopharma companies advance precision medicine, develop new therapies, and design better trials.
</p></span></div></div><div class="home-story-block__offer home-story-block__offer--tomorrow" data-reactid="119"><h6 class="home-story-block__number" data-reactid="120">4</h6><h4 class="home-story-block__h4" data-reactid="121"><span class="contentful-text" data-reactid="122">Supporting Drug Development</span></h4><h5 class="home-story-block__h5" data-reactid="123"><span class="contentful-text" data-reactid="124">The Preferred Partner to BioPharma</span></h5><div class="home-story-block__text" data-reactid="125"><span class="contentful-text" data-reactid="126"><p>We partner with drug developers throughout every stage of drug research and development, 
from target discovery to commercial launch. Today, we are working with more than 30 
	<a href="/insights-and-partnerships/biopharma-partnerships" rel="noopener noreferrer">biopharma partners</a> to accelerate new biomarker-driven treatments. <br />
</p></span></div></div></div></div></section><section class="flex-module flex-module--green flex-module--media-module" data-reactid="127"><div class="flex-module__box flex-module__box--left" data-reactid="128"><h4 class="flex-module__microhead" data-reactid="129">Advancing Cancer Care</h4><h3 class="flex-module__head" data-reactid="130">Each patient’s cancer informs all those cases that will come in the future.</h3><div class="flex-module__line" data-reactid="131">|</div><div class="flex-module__tease" data-reactid="132"><span class="contentful-text" data-reactid="133"><p>Learn more about how we are advancing the field with our FoundationCore-powered <a href="/insights-and-partnerships/foundation-insights" rel="noopener noreferrer">data analytics platform</a>, and our groundbreaking <a target="_blank" href="https://www.foundationmedicine.com/blog/unleashing-the-potential-of-clinico-genomic-information-asco-2017" rel="noopener noreferrer">20,000 patient real-world research dataset</a>.
</p>
<p><strong>Gaurav Singal, MD, VP Data Products &amp; Strategy</strong><br />
</p></span></div></div><div class="flex-module__box flex-module__box--right" data-reactid="134"><img alt="" src="//images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg" srcset="//images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=300 300w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=450 450w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=650 650w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=900 900w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=1200 1200w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=1250 1250w, //images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg?w=1522 1522w" sizes="
    (min-width: 1655px) 828px,
    (min-width: 768px) 50vw,
    calc(100vw)
  " data-reactid="135"/></div></section><section class="home-story-block home-story-block--together" data-reactid="136"><div class="scrollmagic-component" data-reactid="137"><svg class="triangle-svg home-story-block__triangle home-story-block__triangle--together" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 600 600" data-reactid="138"><g class="flat-pattern" fill="none" fill-rule="evenodd" stroke="#F7D18F" stroke-width="2" data-reactid="139"><path d="M-21.4350373,319.176612 L237.918186,319.176612" stroke-dasharray="1000" transform="translate(108.241574, 319.676612) rotate(90.000000) translate(-108.241574, -319.676612) " data-reactid="140"></path><polyline transform="translate(385.370673, 191.246094) rotate(90.000000) translate(-385.370673, -191.246094) " points="319.468329 136.616995 258.124579 245.062308 382.921831 245.875193 512.616767 245.062308" data-reactid="141"></polyline><polyline transform="translate(330.890012, 253.570312) rotate(90.000000) translate(-330.890012, -253.570312) " points="203.319699 146.003906 331.600949 362.71875 458.460324 144.421875 329.3279 144.421875 395.37634 252.447629" data-reactid="142"></polyline><polyline transform="translate(167.600557, 318.945626) rotate(90.000000) translate(-167.600557, -318.945626) " points="39.6549312 376.831952 102.467431 485.804608 295.546182 152.086643" data-reactid="143"></polyline><path d="M281.623047,15.1152344 L156.09668,239.176758" stroke-linecap="square" transform="translate(218.859863, 127.145996) rotate(90.000000) translate(-218.859863, -127.145996) " data-reactid="144"></path><polyline transform="translate(220.864928, 354.820229) rotate(90.000000) translate(-220.864928, -354.820229) " points="58.0446987 467.943583 121.220481 353.771288 383.685157 353.750595 312.632589 241.696875" data-reactid="145"></polyline><path d="M154.790613,271.950961 L286.558562,495.816988" stroke-linecap="square" transform="translate(220.674587, 383.883975) rotate(90.000000) translate(-220.674587, -383.883975) " data-reactid="146"></path><polygon transform="translate(162.623224, 95.823388) rotate(90.000000) translate(-162.623224, -95.823388) " points="258.446612 150.03707 193.934894 39.9417383 66.799836 41.6737883 130.946613 151.705038" data-reactid="147"></polygon></g></svg></div><div class="home-story-block__content" data-reactid="148"><h3 class="home-story-block__h3 home-story-block__h3--together" data-reactid="149"><!-- react-text: 150 -->Better Care <!-- /react-text --><em data-reactid="151">Together</em></h3><div class="home-story-block__offer-set" data-reactid="152"><div class="home-story-block__offer home-story-block__offer--together" data-reactid="153"><h6 class="home-story-block__number" data-reactid="154">5</h6><h4 class="home-story-block__h4" data-reactid="155"><span class="contentful-text" data-reactid="156">Collective Advances</span></h4><h5 class="home-story-block__h5" data-reactid="157"><span class="contentful-text" data-reactid="158">The Power of Collaboration</span></h5><div class="home-story-block__text" data-reactid="159"><span class="contentful-text" data-reactid="160"><p>By sharing our genomic data, we empower researchers on the front lines to generate new connections and insights. Today, we proudly participate in a number of <a rel="noopener noreferrer" href="/blog/shaping-the-future-of-liquid-biopsies">sharing initiatives</a> to accelerate research efforts.<br />
</p></span></div></div><div class="home-story-block__offer home-story-block__offer--together" data-reactid="161"><h6 class="home-story-block__number" data-reactid="162">6</h6><h4 class="home-story-block__h4" data-reactid="163"><span class="contentful-text" data-reactid="164">Transforming Cancer Care</span></h4><h5 class="home-story-block__h5" data-reactid="165"><span class="contentful-text" data-reactid="166">Cultivating an Ecosystem of Partners</span></h5><div class="home-story-block__text" data-reactid="167"><span class="contentful-text" data-reactid="168"><p>Every insight we gain towards better cancer care is multiplied by a <a href="/insights-and-partnerships" rel="noopener noreferrer">hyper-connected network</a> of physicians, biopharma, researchers, patient advocacy organizations and world-leading medical centers. Together, we are transforming cancer care. <br />
</p></span></div></div></div></div></section><section class="flex-module flex-module--blue-rich flex-module--blog-module" data-reactid="169"><div class="flex-module__box flex-module__box--left" data-reactid="170"><h4 class="flex-module__microhead" data-reactid="171">From the Blog</h4><h3 class="flex-module__head" data-reactid="172"><a href="/blog/diving-deeper-into-cancer-immunotherapy-biomarkers" data-reactid="173"><span class="contentful-text" data-reactid="174">Diving Deeper Into Cancer Immunotherapy Biomarkers</span></a></h3><div class="flex-module__line" data-reactid="175">|</div><div class="flex-module__author" data-reactid="176"><span class="contentful-text" data-reactid="177">Phil Stephens, PhD</span><span data-reactid="178"><br data-reactid="179"/><em data-reactid="180"><span class="contentful-text" data-reactid="181">Chief Scientific Officer</span></em></span></div></div><div class="flex-module__box flex-module__box--right flex-module__box--blog-tease" data-reactid="182"><span class="contentful-text" data-reactid="183"><p>Cancer immunotherapy is transforming the treatment landscape for many types of cancer, but identifying those people most likely to benefit from these new treatments is one of the biggest hurdles facing the field. Personalized targeted therapies have traditionally been prescribed based on the presence of single mutations – but immunotherapy isn’t so simple.
</p>
<p>
	Today, one of the most common biomarkers for immunotherapy is a protein called PD-L1. Unfortunately, while patients with high PD-L1 are more likely to respond to immunotherapy, many with high PD-L1 don’t respond, and many with low PD-L1 do.<br />
</p></span><p class="flex-module__cta" data-reactid="184"><a href="/blog/diving-deeper-into-cancer-immunotherapy-biomarkers" data-reactid="185">Read the Article</a></p></div></section><div class="base-layout" data-reactid="186"><section class="page-outro" data-reactid="187"><h2 class="page-outro__head" data-reactid="188">Join Us in the Pursuit of Better</h2><p class="page-outro__body" data-reactid="189"><!-- react-text: 190 -->Find out more about<!-- /react-text --><!-- react-text: 191 --> <!-- /react-text --><a href="/genomic-testing" data-reactid="192">genomic testing</a><!-- react-text: 193 -->, learn more<!-- /react-text --><!-- react-text: 194 --> <!-- /react-text --><a href="/about/" data-reactid="195">about us</a><!-- react-text: 196 -->, or read the latest<!-- /react-text --><!-- react-text: 197 --> <!-- /react-text --><a href="/blog/" data-reactid="198">updates from our blog</a><!-- react-text: 199 -->.<!-- /react-text --></p></section></div></div></div></main><footer class="primary-footer" data-reactid="200"><div class="primary-footer__content base-layout" data-reactid="201"><div class="primary-footer__row" data-reactid="202"><div class="primary-footer__logo" data-reactid="203"><h1 class="primary-footer__logo-h1" data-reactid="204"><a class="primary-footer__logo-h1-link" href="/" data-reactid="205">Foundation Medicine</a></h1></div><nav class="primary-footer__nav" data-reactid="206"><div class="primary-footer__nav-content" data-reactid="207"><div class="primary-footer__nav-links" data-reactid="208"><ul class="primary-footer__nav-list" data-reactid="209"><li class="primary-footer__nav-item primary-footer__nav-item--testing" data-reactid="210"><a class="primary-footer__nav-link" href="/genomic-testing" data-reactid="211">Genomic Testing</a></li><li class="primary-footer__nav-item primary-footer__nav-item--insights" data-reactid="212"><a class="primary-footer__nav-link" href="/insights-and-trials" data-reactid="213">Insights &amp; Trials</a></li><li class="primary-footer__nav-item primary-footer__nav-item--insights" data-reactid="214"><a class="primary-footer__nav-link" href="/partnerships" data-reactid="215">Partnerships</a></li><li class="primary-footer__nav-item primary-footer__nav-item--about" data-reactid="216"><a class="primary-footer__nav-link" href="/about" data-reactid="217">About Us</a></li><li class="primary-footer__nav-item primary-footer__nav-item--blog" data-reactid="218"><a class="primary-footer__nav-link" href="/blog" data-reactid="219">Blog</a></li><li class="primary-footer__nav-item primary-footer__nav-item--investors" data-reactid="220"><a class="primary-footer__nav-link" href="http://investors.foundationmedicine.com" data-reactid="221">Press &amp; Investors</a></li><li class="primary-footer__nav-item primary-footer__nav-item--careers" data-reactid="222"><a class="primary-footer__nav-link" href="/about/careers" data-reactid="223">Careers</a></li><li class="primary-footer__nav-item primary-footer__nav-item--contact" data-reactid="224"><a class="primary-footer__nav-link" href="/contact" data-reactid="225">Contact Us</a></li></ul><div class="primary-footer__sets" data-reactid="226"><div class="primary-footer__set" data-reactid="227"><h3 class="primary-footer__h" data-reactid="228">Genomic Testing</h3><ul class="primary-footer__mini-list" data-reactid="229"><li class="primary-footer__mini-item" data-reactid="230"><a class="primary-footer__mini-link" href="/genomic-testing" data-reactid="231">Testing Overview</a></li><li class="primary-footer__mini-item" data-reactid="232"><a class="primary-footer__mini-link" href="/genomic-testing#support-services" data-reactid="233">Financial Services &amp; Support</a></li><li class="primary-footer__mini-item" data-reactid="234"><a class="primary-footer__mini-link" href="/genomic-testing/order" data-reactid="235">Order a Test</a></li></ul></div><div class="primary-footer__set" data-reactid="236"><h3 class="primary-footer__h" data-reactid="237">Insights &amp; Trials</h3><ul class="primary-footer__mini-list" data-reactid="238"><li class="primary-footer__mini-item" data-reactid="239"><a class="primary-footer__mini-link" href="/insights-and-trials" data-reactid="240">Overview</a></li><li class="primary-footer__mini-item" data-reactid="241"><a class="primary-footer__mini-link" href="/insights-and-trials/foundation-smarttrials" data-reactid="242">FoundationSmartTrials™</a></li><li class="primary-footer__mini-item" data-reactid="243"><a class="primary-footer__mini-link" href="/insights-and-trials/foundation-insights" data-reactid="244">FoundationInsights™</a></li></ul></div><div class="primary-footer__set" data-reactid="245"><h3 class="primary-footer__h" data-reactid="246">Partnerships</h3><ul class="primary-footer__mini-list" data-reactid="247"><li class="primary-footer__mini-item" data-reactid="248"><a class="primary-footer__mini-link" href="/partnerships" data-reactid="249">Overview</a></li><li class="primary-footer__mini-item" data-reactid="250"><a class="primary-footer__mini-link" href="/partnerships/institutional-partnerships" data-reactid="251">Institutional Partnerships</a></li><li class="primary-footer__mini-item" data-reactid="252"><a class="primary-footer__mini-link" href="/partnerships/biopharma-partnerships" data-reactid="253">Biopharma Partnerships</a></li></ul></div></div></div><div class="primary-footer__social" data-reactid="254"><ul class="primary-footer__social-list" data-reactid="255"><li class="primary-footer__social-item" data-reactid="256"><a target="_blank" rel="noopener noreferrer" href="http://linkedin.com/company/foundation-medicine" class="primary-footer__social-link primary-footer__social-link--linkedin" data-reactid="257">LinkedIn</a></li><li class="primary-footer__social-item" data-reactid="258"><a target="_blank" rel="noopener noreferrer" href="https://twitter.com/foundationatcg" class="primary-footer__social-link primary-footer__social-link--twitter" data-reactid="259">Twitter</a></li><li class="primary-footer__social-item" data-reactid="260"><a target="_blank" rel="noopener noreferrer" href="http://youtube.com/FoundationMedicine" class="primary-footer__social-link primary-footer__social-link--youtube" data-reactid="261">YouTube</a></li></ul></div></div></nav></div><div class="primary-footer__legal-privacy" data-reactid="262"><p class="primary-footer__legal" data-reactid="263"><a class="primary-footer__legal-link" href="/pages/legal/" data-reactid="264">Legal &amp; Privacy</a><!-- react-text: 265 --> | <!-- /react-text --><a class="primary-footer__legal-link" href="/pages/licenses" data-reactid="266">Licenses</a></p><p class="primary-footer__legal" data-reactid="267"><span class="primary-footer__legal__copyright" data-reactid="268">© 2017 Foundation Medicine, Inc.</span><!-- react-text: 269 --> <!-- /react-text --><span class="primary-footer__legal__version" data-reactid="270"><!-- react-text: 271 --> v.<!-- /react-text --><!-- react-text: 272 -->1.4.4<!-- /react-text --></span></p></div></div></footer></div></div>
      <script>
        
        window.__PRELOADED_DATA__ = [null,{"page":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"3EB6WOuedqmaa6O0OiooOQ","type":"Entry","createdAt":"2017-02-16T18:08:36.693Z","updatedAt":"2018-01-31T16:10:43.844Z","revision":"35","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"homePage"}},"locale":"en-US"},"fields":{"pageTitle":"Home Page","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"25PGDlmXNeMIOq8wWwQSc8","type":"Asset","createdAt":"2017-05-30T14:15:33.756Z","updatedAt":"2017-05-30T21:06:58.096Z","revision":"2","locale":"en-US"},"fields":{"title":"homepage-hero-gray","description":"Woman in gray shirt looking directly at the camera.","file":{"url":"//images.ctfassets.net/vhribv12lmne/25PGDlmXNeMIOq8wWwQSc8/125eb73deed181bf6bcd38b8672fedd9/home-hero-gray2.jpg","details":{"size":"441230","image":{"width":"740","height":"800"}},"fileName":"home-hero-gray2.jpg","contentType":"image/jpeg"}}},"heroHeading":"The Relentless Pursuit of Better","heroText":"&lt;p&gt;&lt;strong&gt;We never give up&lt;/strong&gt;. We strive to do more for cancer patients - through richer science, deeper insights, and stronger partnerships - providing better cancer care today, and fueling better cancer care tomorrow.\n&lt;/p&gt;","heroPreface":"&lt;p&gt;Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.\n&lt;/p&gt;","heroSlides":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"fS6CWnQ06W8aWg6q60WE8","type":"Entry","createdAt":"2017-12-06T17:17:19.842Z","updatedAt":"2017-12-18T17:31:49.381Z","revision":"5","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"slide"}},"locale":"en-US"},"fields":{"title":"Slide 1 (Home Header)","textToChange":"Care","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"28Yj0y6bagIkAMi2ccKqym","type":"Asset","createdAt":"2017-12-06T17:12:07.172Z","updatedAt":"2018-01-24T20:54:41.230Z","revision":"4","locale":"en-US"},"fields":{"title":"Slide 1 Image (Home Header)","file":{"url":"//images.ctfassets.net/vhribv12lmne/28Yj0y6bagIkAMi2ccKqym/e5845c274eeb6a91f186daa3308e78b6/Patient_5BW_hires_transparent.png","details":{"size":"9988838","image":{"width":"4800","height":"3200"}},"fileName":"Patient_5BW_hires_transparent.png","contentType":"image/png"}}}}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"1VzCxZgDteYwwouMs60eS2","type":"Entry","createdAt":"2017-12-06T17:17:24.225Z","updatedAt":"2017-12-18T17:32:06.123Z","revision":"5","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"slide"}},"locale":"en-US"},"fields":{"title":"Slide 2 (Home Header)","textToChange":"Options","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"4Hik1nTwDKGIoY4E4mkuua","type":"Asset","createdAt":"2017-12-06T17:13:53.630Z","updatedAt":"2018-01-24T20:56:01.566Z","revision":"4","locale":"en-US"},"fields":{"title":"Slide 2 Image (Home Header)","file":{"url":"//images.ctfassets.net/vhribv12lmne/4Hik1nTwDKGIoY4E4mkuua/a22fd33f51e93ad3fc0b493c25180fe6/Patient_3BW_hires_transparent.png","details":{"size":"9284228","image":{"width":"4800","height":"3200"}},"fileName":"Patient_3BW_hires_transparent.png","contentType":"image/png"}}}}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"2dXwnT3GrucaWOa4qGsAKu","type":"Entry","createdAt":"2017-12-06T17:17:30.065Z","updatedAt":"2018-01-24T21:04:31.570Z","revision":"6","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"slide"}},"locale":"en-US"},"fields":{"title":"Slide 3 (Home Header)","textToChange":"Insights","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"6FeOM6LzZ6cyI4QGkUyicq","type":"Asset","createdAt":"2017-12-06T17:15:02.605Z","updatedAt":"2018-01-24T20:56:54.108Z","revision":"3","locale":"en-US"},"fields":{"title":"Slide 3 Image (Home Header)","file":{"url":"//images.ctfassets.net/vhribv12lmne/6FeOM6LzZ6cyI4QGkUyicq/73193501f80e00ca6eb28367fb7b2b77/Patient_6BW_hires_transparent.png","details":{"size":"9463045","image":{"width":"4800","height":"3200"}},"fileName":"Patient_6BW_hires_transparent.png","contentType":"image/png"}}}}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"2rKrvk8NAcecYW6yMs0KWw","type":"Entry","createdAt":"2017-12-06T17:17:35.473Z","updatedAt":"2018-01-24T21:04:45.119Z","revision":"6","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"slide"}},"locale":"en-US"},"fields":{"title":"Slide 4 (Home Header)","textToChange":"Science","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"6ca3J1ERDqAG84eqagsE6c","type":"Asset","createdAt":"2017-12-06T17:16:05.637Z","updatedAt":"2018-01-24T20:57:42.152Z","revision":"3","locale":"en-US"},"fields":{"title":"Slide 4 Image (Home Header)","file":{"url":"//images.ctfassets.net/vhribv12lmne/6ca3J1ERDqAG84eqagsE6c/49d4e435efc2018d9f841a0878d5de32/Patient_4BW_hires_transparent.png","details":{"size":"6745001","image":{"width":"4800","height":"3200"}},"fileName":"Patient_4BW_hires_transparent.png","contentType":"image/png"}}}}}],"todayStoryBlocks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"1uNcgOS4LWU4Q0S482EqQW","type":"Entry","createdAt":"2017-04-12T20:08:48.510Z","updatedAt":"2017-05-24T14:29:02.577Z","revision":"6","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"Genomic Testing","heading":"Comprehensive Genomic Profiling","text":"&lt;p&gt;Our &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;/genomic-testing&quot;&gt;portfolio of genomic tests&lt;/a&gt; is the leading platform for comprehensive genomic profiling.  We interrogate more than 300 genes across all four classes of genomic alterations to help understand the genomic makeup of a patient's tumor.&lt;br&gt;\n&lt;/p&gt;"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"46TsHQaZVeYEOAi2Ksue48","type":"Entry","createdAt":"2017-04-12T20:09:17.485Z","updatedAt":"2017-05-24T14:29:33.434Z","revision":"10","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"Molecular Insights","heading":"Valuable Insights, Actionable Options","text":"&lt;p&gt;We match each patient’s unique profile to known targeted therapies, immunotherapies and clinical trials and offer decision support tools, &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;/genomic-testing#support-services&quot;&gt;financial assistance&lt;/a&gt;, and technology solutions to help streamline patient care.\n&lt;/p&gt;"}}],"tomorrowStoryBlocks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"4TUAUGJheoKKC2qAqSAkEo","type":"Entry","createdAt":"2017-04-12T20:09:46.897Z","updatedAt":"2018-01-23T15:30:48.271Z","revision":"19","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"More Than Numbers","heading":"Insights, Not Just Information","text":"&lt;p&gt;\n\tOur unique knowledgebase, &lt;a href=&quot;http://www.foundationmedicine.com/insights-and-partnerships/foundation-insights&quot; rel=&quot;noopener noreferrer&quot;&gt;FoundationCore™&lt;/a&gt;, is one of the world's largest cancer genomic databases, with more than 180,000 anonymized patient records, designed to help researchers and biopharma companies advance precision medicine, develop new therapies, and design better trials.\n&lt;/p&gt;"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"6qj4f8JqPCasa0KYmqMA2u","type":"Entry","createdAt":"2017-04-12T20:10:12.638Z","updatedAt":"2017-05-25T15:50:54.072Z","revision":"7","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"Supporting Drug Development","heading":"The Preferred Partner to BioPharma","text":"&lt;p&gt;We partner with drug developers throughout every stage of drug research and development, \nfrom target discovery to commercial launch. Today, we are working with more than 30 \n\t&lt;a href=&quot;/insights-and-partnerships/biopharma-partnerships&quot; rel=&quot;noopener noreferrer&quot;&gt;biopharma partners&lt;/a&gt; to accelerate new biomarker-driven treatments. &lt;br&gt;\n&lt;/p&gt;"}}],"togetherStoryBlocks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"4y9oq0uAnKU8QciSuoMScY","type":"Entry","createdAt":"2017-04-12T20:10:37.499Z","updatedAt":"2017-05-30T19:59:17.094Z","revision":"6","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"Collective Advances","heading":"The Power of Collaboration","text":"&lt;p&gt;By sharing our genomic data, we empower researchers on the front lines to generate new connections and insights. Today, we proudly participate in a number of &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;/blog/shaping-the-future-of-liquid-biopsies&quot;&gt;sharing initiatives&lt;/a&gt; to accelerate research efforts.&lt;br&gt;\n&lt;/p&gt;"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"30FjHhbSsE60K6SW6Q6UEM","type":"Entry","createdAt":"2017-04-12T20:10:58.505Z","updatedAt":"2017-05-25T16:57:20.090Z","revision":"4","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"storyBlock"}},"locale":"en-US"},"fields":{"microHeading":"Transforming Cancer Care","heading":"Cultivating an Ecosystem of Partners","text":"&lt;p&gt;Every insight we gain towards better cancer care is multiplied by a &lt;a href=&quot;/insights-and-partnerships&quot; rel=&quot;noopener noreferrer&quot;&gt;hyper-connected network&lt;/a&gt; of physicians, biopharma, researchers, patient advocacy organizations and world-leading medical centers. Together, we are transforming cancer care. &lt;br&gt;\n&lt;/p&gt;"}}],"homeModuleInterstitials":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"2fxXfn83FW4cOUMK06SgsI","type":"Entry","createdAt":"2017-04-18T16:01:06.035Z","updatedAt":"2017-06-21T13:43:38.612Z","revision":"8","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"mediaModule"}},"locale":"en-US"},"fields":{"microHeading":"Patient Story","heading":"Dealing with cancer is not just dealing with the cancer. It’s treating the whole person.","styleAsPullQuote":{},"tease":"&lt;p&gt;Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining FoundationOne&lt;sup&gt;®&lt;/sup&gt;, a comprehensive genomic profiling test.\n&lt;/p&gt;","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"5oAEyFOY9y00sKKa0yEqmU","type":"Asset","createdAt":"2017-04-06T16:55:21.644Z","updatedAt":"2017-05-30T16:22:51.748Z","revision":"4","locale":"en-US"},"fields":{"title":"temp-module2","file":{"url":"//images.ctfassets.net/vhribv12lmne/5oAEyFOY9y00sKKa0yEqmU/73119b0ffe2a2b21ac77a2fd42766b78/Christine_duotoneDKSlate_765x900.jpg","details":{"size":"313859","image":{"width":"765","height":"900"}},"fileName":"Christine_duotoneDKSlate_765x900.jpg","contentType":"image/jpeg"}}},"fullBleedImage":{},"youtubeLink":"https://www.youtube.com/watch?v=Bhduw3l8QIw"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"5lU9FLKpvqaMuqamC6EUaO","type":"Entry","createdAt":"2017-04-20T20:41:41.657Z","updatedAt":"2017-08-17T19:19:43.894Z","revision":"25","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"mediaModule"}},"locale":"en-US"},"fields":{"microHeading":"Advancing Cancer Care","heading":"Each patient’s cancer informs all those cases that will come in the future.","styleAsPullQuote":false,"tease":"&lt;p&gt;Learn more about how we are advancing the field with our FoundationCore-powered &lt;a href=&quot;/insights-and-partnerships/foundation-insights&quot; rel=&quot;noopener noreferrer&quot;&gt;data analytics platform&lt;/a&gt;, and our groundbreaking &lt;a target=&quot;_blank&quot; href=&quot;https://www.foundationmedicine.com/blog/unleashing-the-potential-of-clinico-genomic-information-asco-2017&quot; rel=&quot;noopener noreferrer&quot;&gt;20,000 patient real-world research dataset&lt;/a&gt;.\n&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Gaurav Singal, MD, VP Data Products &amp;amp; Strategy&lt;/strong&gt;&lt;br&gt;\n&lt;/p&gt;","image":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"U7F3nOAx8IYWWUOmAwSQy","type":"Asset","createdAt":"2017-06-01T20:45:58.686Z","updatedAt":"2017-06-01T20:45:58.686Z","revision":"1","locale":"en-US"},"fields":{"title":"Gaurav edited 765x900","file":{"url":"//images.ctfassets.net/vhribv12lmne/U7F3nOAx8IYWWUOmAwSQy/b5e31678137ae506e343f3c81d0d2e0f/Gaurav_edited_765x900.jpg","details":{"size":"1420018","image":{"width":"1522","height":"1790"}},"fileName":"Gaurav_edited_765x900.jpg","contentType":"image/jpeg"}}},"fullBleedImage":{}}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"5E1qAjpMcMcieoOYsQ0m00","type":"Entry","createdAt":"2017-04-18T15:51:46.242Z","updatedAt":"2017-05-30T20:34:32.853Z","revision":"10","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"blogModule"}},"locale":"en-US"},"fields":{"microHeading":"From the Blog","heading":"Diving Deeper Into Cancer Immunotherapy Biomarkers","styleAsPullQuote":false,"blogArticle":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"vhribv12lmne"}},"id":"16wLQSbwc0uA4QgAO8yq6a","type":"Entry","createdAt":"2017-04-28T15:41:19.568Z","updatedAt":"2017-05-29T13:45:34.412Z","revision":"2","contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"basicArticle"}},"locale":"en-US"},"fields":{"pageTitle":"Diving Deeper Into Cancer Immunotherapy Biomarkers","slug":"diving-deeper-into-cancer-immunotherapy-biomarkers","publishedAt":"2017-04-01","authorName":"Phil Stephens, PhD","authorTitle":"Chief Scientific Officer","mainText":"&lt;p&gt;Cancer immunotherapy is transforming the treatment landscape for many types of cancer, but identifying those people most likely to benefit from these new treatments is one of the biggest hurdles facing the field. Personalized targeted therapies have traditionally been prescribed based on the presence of single mutations – but immunotherapy isn’t so simple.\n&lt;/p&gt;\n&lt;p&gt;The biology of each person’s cancer and immune system is different, and this variability can result in different responses to this class of medicine. For example, only about &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;http://www.nejm.org/doi/full/10.1056/NEJMoa1302369&quot; target=&quot;_blank&quot;&gt;20-40%&lt;/a&gt; of patients respond to checkpoint inhibitor immunotherapies.\n&lt;/p&gt;\n&lt;h4&gt;Matching the Complexity of Cancer&lt;/h4&gt;\n&lt;p&gt;The task of determining who will benefit from immunotherapy is not only important, but an enormous challenge. Today, one of the most common biomarkers for immunotherapy is a protein called PD-L1. Unfortunately, while patients with high PD-L1 are more likely to respond to immunotherapy, many with high PD-L1 don’t respond, and many with low PD-L1 do. It is becoming apparent that PD-L1 expression alone is not a sufficient predictor of response.\n&lt;/p&gt;\n&lt;p&gt;To make a more informed treatment decision and take the next step in personalized cancer immunotherapy, we need a comprehensive view of protein biomarkers, mutational load and genomic alterations. At this year’s AACR meeting, we are excited to present new results focused on that next step.\n&lt;/p&gt;\n&lt;p&gt;One exciting new biomarker for predicting response to cancer immunotherapy is tumor mutational burden (&lt;a rel=&quot;noopener noreferrer&quot; href=&quot;/blog/predicting-cancer-immunotherapy-response-with-tumor-mutational-burden-tmb&quot; target=&quot;_blank&quot;&gt;TMB&lt;/a&gt;). TMB provides a quantitative estimate of the total number of mutations in the coding region of a tumor’s genome. Tumor cells that have higher levels of TMB may be more recognizable by the immune system, and may therefore facilitate a stronger immune response to checkpoint inhibitors.\n&lt;/p&gt;\n&lt;p&gt;Indeed, our &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;http://www.abstractsonline.com/pp8/#!/4292/presentation/1298&quot; target=&quot;_blank&quot;&gt;new results&lt;/a&gt; to be presented at AACR validate the ability of TMB to predict responses to FDA-approved checkpoint inhibitor cancer immunotherapies across multiple tumor types, including lung cancer, melanoma and bladder cancer.\n&lt;/p&gt;\n&lt;p&gt;However, given the complexity of cancer, even with the addition of TMB to current approaches, immunotherapy response cannot be predicted perfectly. To maximize benefit for individual patients, we need to identify and integrate additional predictive markers.\n&lt;/p&gt;\n&lt;h4&gt;Finding New Ways to Predict Responses&lt;/h4&gt;\n&lt;p&gt;Using comprehensive genomic profiling (CGP) approaches in people with non-small cell lung cancer (NSCLC), we may have &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;http://www.abstractsonline.com/pp8/#!/4292/presentation/1306&quot; target=&quot;_blank&quot;&gt;identified&lt;/a&gt; additional markers, findings which we will also discuss at the &lt;a rel=&quot;noopener noreferrer&quot; href=&quot;http://www.abstractsonline.com/pp8/#!/4292/presentation/10125&quot; target=&quot;_blank&quot;&gt;AACR Bridging Big Data and Clinical Practice Session&lt;/a&gt;.\n&lt;/p&gt;\n&lt;p&gt;Specifically, we discovered that even in patients with low TMB, many lung cancers were highly responsive to immunotherapies if they also had mutations in the BRAF or MET genes. Evaluating these results in addition to TMB could help identify additional patients who may benefit from new immunotherapies.\n&lt;/p&gt;\n&lt;p&gt;Additionally, we discovered that in people with high TMB, those with STK11 alterations were much less likely to respond to immunotherapy. This suggests that these patients might benefit from another treatment approach instead. While these results will require clinical validation before being routinely integrated into patient care, together they may help us more accurately identify people who will or will not respond to immunotherapy, so physicians can make more informed and precise decisions for their patients. While our work at Foundation Medicine has focused on NSCLC, these STK11, BRAF and MET alterations could also affect immunotherapy response in other tumor types. This is an exciting area for ongoing research and discovery.\n&lt;/p&gt;\n&lt;p&gt;Perhaps equally notable is how these findings were discovered – through marrying sophisticated genomic data with real-world clinical outcomes. These “clinical-genomic” datasets, whether from new analyses of clinical trial data, or novel methodologies like the EMR-linked dataset Foundation Medicine has developed in partnership with Flatiron Health, have the potential to accelerate precision medicine and our ability to match the right therapy to the right person.\n&lt;/p&gt;\n&lt;h4&gt;Doing Our Part&lt;/h4&gt;\n&lt;p&gt;Despite the profound benefit cancer immunotherapy provides for some, there is still a need for better predictive biomarkers to classify both responders and non-responders. Clearly identifying patients who won’t respond to specific drugs is just as important as identifying those who will, saving the entire cancer ecosystem precious time and resources. Together, we can help ensure that patients receive a treatment that is likely to work – avoiding unnecessary side effects and wasted time with one that won’t. We can help the pharmaceutical industry better discriminate the impact of their drug. And we can help researchers develop new hypotheses and potentially discover new therapies.\n&lt;/p&gt;\n&lt;p&gt;Foundation Medicine is dedicated to seizing opportunities like these to advance biomarker development. Together with the rest of the community, we can push toward the future of precision medicine.\n&lt;/p&gt;\n&lt;p&gt;&lt;a rel=&quot;noopener noreferrer&quot; href=&quot;/insights-and-partnerships/biopharma-partnerships&quot;&gt;Discover more about comprehensive genomic profiling and how our assays are advancing precision medicine.&lt;/a&gt;\n&lt;/p&gt;"}},"excerpt":"&lt;p&gt;Cancer immunotherapy is transforming the treatment landscape for many types of cancer, but identifying those people most likely to benefit from these new treatments is one of the biggest hurdles facing the field. Personalized targeted therapies have traditionally been prescribed based on the presence of single mutations – but immunotherapy isn’t so simple.\n&lt;/p&gt;\n&lt;p&gt;\n\tToday, one of the most common biomarkers for immunotherapy is a protein called PD-L1. Unfortunately, while patients with high PD-L1 are more likely to respond to immunotherapy, many with high PD-L1 don’t respond, and many with low PD-L1 do.&lt;br&gt;\n&lt;/p&gt;"}}]}}}];
        window.process = { env: {"isClient":true,"accountLink":"https://reporting.foundationmedicine.com/account","cookieDomain":".foundationmedicine.com","dashboardLink":"https://home.foundationmedicine.com","deliveryToken":"a9302641582cef6fb9bc1ee25ed7652ad14322a22a26e5559f64aba8e880ae65","forgotPasswordLink":"https://home.foundationmedicine.com/forgot-password","gaTrackingCode":"UA-27522741-1","loginEndpoint":"https://home.foundationmedicine.com","NODE_ENV":"production","previewToken":"f4b2543a1417d1f0cc135eea6c36ec7f05f03e637b6c476784316e3a8a9cd60e","signupLink":"https://home.foundationmedicine.com/signup","spaceId":"vhribv12lmne","siteUrl":"https://www.foundationmedicine.com","version":"1.4.4","displayApprovalBanner":"true","displayF1CDxPage":"true"} };
        if (Object.freeze) {
          Object.freeze(process);
          Object.freeze(process.env);
        }
      </script>
      <script src="/index.js"></script>
    </body>
    </html>